ORIC Pharmaceuticals Inc

ORICNASDAQ · USD
12.81USD-0.07 (-0.55%)
3210

ORIC Pharmaceuticals Inc (ORIC) Historical Volatility

ORIC 30-day historical volatility is 45%. This ranks in the 13th percentile of readings over the past year.

Read more

Tracking ORIC historical volatility helps you see how much ORIC Pharmaceuticals Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, ORIC Pharmaceuticals Inc's HV tells you what really happened. Use our scanner to monitor ORIC 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The ORIC 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing ORIC Pharmaceuticals Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations.

The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts ORIC Pharmaceuticals Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where ORIC HV is running hot, cold, or in line. Make the ORIC 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 17, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 17, 2026

See how volatility has moved over time

Track ORIC historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial